Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework - PubMed (original) (raw)
Review
Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework
Jon Richmond. ILAR J. 2002.
Abstract
Many are critical of how regulatory testing practices have evolved and become established--critical both of the scientific rational and the animal welfare costs. The test of whether we are more enlightened than our predecessors will be whether, armed with more powerful scientific insights and a better understanding of animal welfare, we can ensure that the best animal welfare and the best science drive and shape future developments in regulatory testing. Conducting the most humane animal-based regulatory testing requires establishing and maintaining a constructive dialogue between stakeholders and acknowledging the common ground that unites. Inclusive processes with stakeholders prepared to offer public, rational justifications for their policies and processes are essential if best practice is to be identified and implemented. There is general agreement that the best animal welfare results in the best science; that regulatory requirements based on an understanding of mechanisms and early relevant biomarkers result in elegant and valid science. Thus, "alternative" methods enabling replacement, reduction, or refinement (the 3Rs) are in reality often more scientifically "advanced" and scientifically valid methods. These principles provided the incentive and framework for recent initiatives in the United Kingdom to enhance the quality of the data prepared for regulatory submission while better protecting the welfare of the animals used. Some remaining 3R opportunities are explored in this paper, and some of the commonly encountered myths about regulatory testing and perceived barriers to change are challenged. Current "threats" may indeed offer opportunities for ensuring that sound science and the best animal welfare underpin developments in regulatory testing.
Similar articles
- Culture of Care: Organizational Responsibilities.
Brown MJ, Symonowicz C, Medina LV, Bratcher NA, Buckmaster CA, Klein H, Anderson LC. Brown MJ, et al. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 2. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 2. PMID: 29787190 Free Books & Documents. Review. - Future improvements and implementation of animal care practices within the animal testing regulatory environment.
Guittin P, Decelle T. Guittin P, et al. ILAR J. 2002;43 Suppl:S80-4. doi: 10.1093/ilar.43.suppl_1.s80. ILAR J. 2002. PMID: 12388857 Review. - Possibilities for refinement and reduction: future improvements within regulatory testing.
Stephens ML, Conlee K, Alvino G, Rowan AN. Stephens ML, et al. ILAR J. 2002;43 Suppl:S74-9. doi: 10.1093/ilar.43.suppl_1.s74. ILAR J. 2002. PMID: 12388856 Review. - The new paradigm in animal testing - "3Rs alternatives".
Poh WT, Stanslas J. Poh WT, et al. Regul Toxicol Pharmacol. 2024 Nov;153:105705. doi: 10.1016/j.yrtph.2024.105705. Epub 2024 Sep 20. Regul Toxicol Pharmacol. 2024. PMID: 39299677 Review.
Cited by
- Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a Glance.
Zielińska A, Costa B, Ferreira MV, Miguéis D, Louros JMS, Durazzo A, Lucarini M, Eder P, Chaud MV, Morsink M, Willemen N, Severino P, Santini A, Souto EB. Zielińska A, et al. Int J Environ Res Public Health. 2020 Jun 28;17(13):4657. doi: 10.3390/ijerph17134657. Int J Environ Res Public Health. 2020. PMID: 32605255 Free PMC article. Review. - Leukocyte reduction filters as an alternative source of peripheral blood leukocytes for research.
Ferdowsi S, Abbasi-Malati Z, Pourfathollah AA. Ferdowsi S, et al. Hematol Transfus Cell Ther. 2021 Oct-Dec;43(4):494-498. doi: 10.1016/j.htct.2020.10.963. Epub 2020 Dec 24. Hematol Transfus Cell Ther. 2021. PMID: 33422490 Free PMC article. Review. - Substitute of Animals in Drug Research: An Approach Towards Fulfillment of 4R's.
Arora T, Mehta AK, Joshi V, Mehta KD, Rathor N, Mediratta PK, Sharma KK. Arora T, et al. Indian J Pharm Sci. 2011 Jan;73(1):1-6. doi: 10.4103/0250-474X.89750. Indian J Pharm Sci. 2011. PMID: 22131615 Free PMC article. - Lactic acid bacteria exhibit similar antioxidant capacities in _Caenorhabditis elegans_- and _Campylobacter jejuni_-infected mice.
Jin X, He Y, Liu Z, Zhou Y, Chen X, Wang G, Sun Z, Zhao J, Zhang H, Chen W. Jin X, et al. RSC Adv. 2020 Jan 21;10(6):3329-3342. doi: 10.1039/c9ra06105c. eCollection 2020 Jan 16. RSC Adv. 2020. PMID: 35497738 Free PMC article. - Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris).
Castillo EJ, Messer JG, Abraham AM, Jiron JM, Alekseyenko AV, Israel R, Thomas S, Gonzalez-Perez GM, Croft S, Gohel A, Bhattacharyya I, Yarrow JF, Novince CM, Kimmel DB, Aguirre JI. Castillo EJ, et al. Bone. 2021 Apr;145:115866. doi: 10.1016/j.bone.2021.115866. Epub 2021 Jan 27. Bone. 2021. PMID: 33515777 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources